CAESAREA, Israel, Sept. 7, 2017 /PRNewswire/ -- DarioHealth Corp.
(NASDAQ: DRIO), a leading global digital health company with mobile
health and big data solutions, today announced the launch of its
Dario app for certain leading Android smart mobile devices (SMD) in
the U.S. The company's Dario Blood Glucose Monitoring System (BGMS)
is now available and ready to ship its to Android users in the
U.S.
This launch opens a significant U.S. market opportunity for
DarioHealth, as its flagship Dario app is now available in Google
Play's U.S. app store for specific SMDs to be used with the Dario
BGMS.
Erez Raphael, Chairman and CEO of
DarioHealth, commented, "We are very excited to have reached this
release date for the Dario app on certain Android devices. With
this launch, the Dario app now accessible to many more SMD users in
the U.S. This continues DarioHealth's U.S. market progress, and
opens the door for potential wide-scale expansion in this pivotal
market. The Dario BGMS is an affordable device that simplifies
diabetes management for people with diabetes via their smartphone.
With the Android availability, we believe we are poised to continue
our sequential quarterly growth and hope to make 2017 a
record-breaking year."
Dror Bacher, COO of DarioHealth,
commented, "Our products have undergone rigorous testing to ensure
they meet the highest standards. I believe Android users in the
U.S. will be very pleased with our product offering, which is
fairly priced and on par with many insurance co-pay
plans."
The compact all-in-one system helps people with diabetes monitor
their blood sugar levels and proactively manages their diabetes
using their smartphone. Dario connects via a headphone jack to turn
a mobile device into a glucose monitor, and incorporates a lancing
device and test strips together with the meter in an all-in-one
easy to carry device to take blood glucose measurements on the
spot. Unlike conventional glucose monitors, there is no carrying
case or batteries to replace. Dario provides real-time and
historical blood glucose data to allow health care providers to
spot patterns, recommend treatments and support behavior changes.
Dario's web interface also makes it easy for users to share health
information with healthcare providers and loved ones.
About DarioHealth Corp.
DarioHealth Corp. is a leading global digital health company
serving tens of thousands of users with dynamic mobile health
solutions. We believe people deserve the best tools to manage their
treatment, and harnessing big data, we have developed a unique way
for our users to analyze and personalize their diabetes management.
With our smart diabetes solution, users have direct access to track
and monitor all facets of diabetes, without having the disease slow
them down. The acclaimed Dario™ Blood Glucose Monitoring System
all-in-one blood glucose meter and native smartphone app gives
users an unrivaled method for self-diabetes management. DarioHealth
is headquartered in Caesarea,
Israel with a regional office in Burlington, Massachusetts. For more
information, visit http://mydario.investorroom.com/.
Cautionary Note Regarding Forward-Looking Statements
This news release and the statements of representatives and
partners of DarioHealth Corp. (the "Company") related thereto
contain or may contain forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
Statements that are not statements of historical fact may be deemed
to be forward-looking statements. Without limiting the generality
of the foregoing, words such as "plan," "project," "potential,"
"seek," "may," "will," "expect," "believe," "anticipate," "intend,"
"could," "estimate," or "continue" are intended to identify
forward-looking statements. For example, when the Company states
that the Dario application for certain Android devices opens a
significant market opportunity and the potential for wide-scale
expansion in the U.S., and that with the Android availability, it
believes it is poised to continue its sequential quarterly growth
and hopes to make 2017 a record-breaking year, it is using
forward-looking statements. Readers are cautioned that certain
important factors may affect the Company's actual results and could
cause such results to differ materially from any forward-looking
statements that may be made in this news release. Factors that may
affect the Company's results include, but are not limited to,
regulatory approvals, product demand, market acceptance, impact of
competitive products and prices, product development,
commercialization or technological difficulties, the success or
failure of negotiations and trade, legal, social and economic
risks, and the risks associated with the adequacy of existing cash
resources. Additional factors that could cause or contribute to
differences between the Company's actual results and
forward-looking statements include, but are not limited to, those
risks discussed in the Company's filings with the U.S. Securities
and Exchange Commission. Readers are cautioned that actual results
(including, without limitation, the timing for and results of the
Company's commercial and regulatory plans for Dario™) may differ
significantly from those set forth in the forward-looking
statements. The Company undertakes no obligation to publicly update
any forward-looking statements, whether as a result of new
information, future events or otherwise, except as required by
applicable law.
DarioHealth Corporate and Media Contact
Shmuel Herschberg
Marketing Director
shmuel@mydario.com
+1-914-775-5548
DarioHealth Investor Relations Contact
Hayden IR
Stephen Hart
DRIO@HaydenIR.com
+1-646-415-8972
View original
content:http://www.prnewswire.com/news-releases/dariohealth-launches-its-dario-app-in-the-google-play-store-expanding-its-us-market-reach-300515449.html
SOURCE DarioHealth Corp.